Ingela Hallberg

Ingela Hallberg M.D., joined Moligo’s board in 2022.

Ingela boasts more than two decades of experience in the pharmaceutical industry, having held leadership roles in clinical research and development and medical affairs in both regional and global capacities, and across various therapeutic areas. In 2019, she established her own business, serving startups and mid-sized life science companies with a focus on clinical development, medical and commercial strategies, and business growth.

Ingela holds a medical degree from the University of Gothenburg and previously worked as a cardiologist at Sahlgrenska University Hospital in Gothenburg.